Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aska Pharmaceutical Co Ltd
MSD KK
Original Assignee
Grelan Pharmaceutical Co Ltd
Banyu Phamaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grelan Pharmaceutical Co Ltd, Banyu Phamaceutical Co LtdfiledCriticalGrelan Pharmaceutical Co Ltd
Priority to ES508177ApriorityCriticalpatent/ES508177A0/en
Publication of ES8300752A1publicationCriticalpatent/ES8300752A1/en
Publication of ES508177A0publicationCriticalpatent/ES508177A0/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Derivatives are provided of N-phthalidyl-5-fluorouracil represented by the general formula <IMAGE> where one of R1 and R2 represents a phthalidyl group <IMAGE> (where R3 is a hydrogen atom, a halogen atom or a group selected from an alkoxyl group or alkoyl group) and the other represents a hydrogen atom, an acyl group or a cyclic ether group <IMAGE> (where n is 1 or 2); or R1 and R2 represent the same phthalidyl group <IMAGE> (where R3 is as defined above), compounds which have anti- tumoural activity and reduced toxicity, and are capable of being used as anti-cancer agents.
ES508177A1981-12-211981-12-21
"A PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF N-FTALIDIL-5-FLUOROURACILO".
GrantedES508177A0
(en)